Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 98 entries
Sorted by: Best Match Show Resources per page
President's page: fighting terrorism: our role as physicians.

Journal of the American College of Cardiology

Zipes DP.
PMID: 11849877
J Am Coll Cardiol. 2002 Feb 20;39(4):739-40. doi: 10.1016/s0735-1097(02)01683-2.

No abstract available.

Cite
Zipes DP. President's page: fighting terrorism: our role as physicians. J Am Coll Cardiol. 2002;39(4):739-40doi: 10.1016/s0735-1097(02)01683-2.
Zipes, D. P. (2002). President's page: fighting terrorism: our role as physicians. Journal of the American College of Cardiology, 39(4), 739-40. https://doi.org/10.1016/s0735-1097(02)01683-2
Zipes, Douglas P. "President's page: fighting terrorism: our role as physicians." Journal of the American College of Cardiology vol. 39,4 (2002): 739-40. doi: https://doi.org/10.1016/s0735-1097(02)01683-2
Zipes DP. President's page: fighting terrorism: our role as physicians. J Am Coll Cardiol. 2002 Feb 20;39(4):739-40. doi: 10.1016/s0735-1097(02)01683-2. PMID: 11849877.
Copy Download .nbib Format: NLM
Optical mapping of cardiac arrhythmias.

Indian pacing and electrophysiology journal

Arora R, Das MK, Zipes DP, Wu J.
PMID: 16943918
Indian Pacing Electrophysiol J. 2003 Oct 01;3(4):187-96.

No abstract available.

Cite
Arora R, Das MK, Zipes DP, et al. Optical mapping of cardiac arrhythmias. Indian Pacing Electrophysiol J. 2003;3(4):187-96
Arora, R., Das, M. K., Zipes, D. P., & Wu, J. (2003). Optical mapping of cardiac arrhythmias. Indian pacing and electrophysiology journal, 3(4), 187-96.
Arora, Rishi, et al. "Optical mapping of cardiac arrhythmias." Indian pacing and electrophysiology journal vol. 3,4 (2003): 187-96.
Arora R, Das MK, Zipes DP, Wu J. Optical mapping of cardiac arrhythmias. Indian Pacing Electrophysiol J. 2003 Oct 01;3(4):187-96. PMID: 16943918; PMCID: PMC1502051.
Copy Download .nbib Format: NLM
Impact of curative radiotherapy on the immune status of patients with localized prostate cancer.

Oncoimmunology

Eckert F, Schaedle P, Zips D, Schmid-Horch B, Rammensee HG, Gani C, Gouttefangeas C.
PMID: 30393582
Oncoimmunology. 2018 Aug 27;7(11):e1496881. doi: 10.1080/2162402X.2018.1496881. eCollection 2018.

Combination of radiotherapy with immunotherapy has become an attractive concept for the treatment of cancer. The objective of this study was to assess the effect of curative, normofractionated radiotherapy on peripheral immune lymphocytes in prostate cancer patients, in order...

Cite
Eckert F, Schaedle P, Zips D, et al. Impact of curative radiotherapy on the immune status of patients with localized prostate cancer. Oncoimmunology. 2018;7(11):e1496881doi: 10.1080/2162402X.2018.1496881.
Eckert, F., Schaedle, P., Zips, D., Schmid-Horch, B., Rammensee, H. G., Gani, C., & Gouttefangeas, C. (2018). Impact of curative radiotherapy on the immune status of patients with localized prostate cancer. Oncoimmunology, 7(11), e1496881. https://doi.org/10.1080/2162402X.2018.1496881
Eckert, Franziska, et al. "Impact of curative radiotherapy on the immune status of patients with localized prostate cancer." Oncoimmunology vol. 7,11 (2018): e1496881. doi: https://doi.org/10.1080/2162402X.2018.1496881
Eckert F, Schaedle P, Zips D, Schmid-Horch B, Rammensee HG, Gani C, Gouttefangeas C. Impact of curative radiotherapy on the immune status of patients with localized prostate cancer. Oncoimmunology. 2018 Aug 27;7(11):e1496881. doi: 10.1080/2162402X.2018.1496881. eCollection 2018. PMID: 30393582; PMCID: PMC6208674.
Copy Download .nbib Format: NLM
Shared Moments.

Arrhythmia & electrophysiology review

Zipes DP.
PMID: 28603620
Arrhythm Electrophysiol Rev. 2017 Apr;6(1):23. doi: 10.15420/aer.2017.6.1:PP11.

No abstract available.

Cite
Zipes DP. Shared Moments. Arrhythm Electrophysiol Rev. 2017;6(1):23doi: 10.15420/aer.2017.6.1:PP11.
Zipes, D. P. (2017). Shared Moments. Arrhythmia & electrophysiology review, 6(1), 23. https://doi.org/10.15420/aer.2017.6.1:PP11
Zipes, Douglas P. "Shared Moments." Arrhythmia & electrophysiology review vol. 6,1 (2017): 23. doi: https://doi.org/10.15420/aer.2017.6.1:PP11
Zipes DP. Shared Moments. Arrhythm Electrophysiol Rev. 2017 Apr;6(1):23. doi: 10.15420/aer.2017.6.1:PP11. PMID: 28603620; PMCID: PMC5463298.
Copy Download .nbib Format: NLM
Physicians Writing Fiction.

Arrhythmia & electrophysiology review

Zipes DP.
PMID: 31463052
Arrhythm Electrophysiol Rev. 2019 Jul;8(3):156-160. doi: 10.15420/aer.2019.8.3.ED1.

No abstract available.

Cite
Zipes DP. Physicians Writing Fiction. Arrhythm Electrophysiol Rev. 2019;8(3):156-160doi: 10.15420/aer.2019.8.3.ED1.
Zipes, D. P. (2019). Physicians Writing Fiction. Arrhythmia & electrophysiology review, 8(3), 156-160. https://doi.org/10.15420/aer.2019.8.3.ED1
Zipes, Douglas P. "Physicians Writing Fiction." Arrhythmia & electrophysiology review vol. 8,3 (2019): 156-160. doi: https://doi.org/10.15420/aer.2019.8.3.ED1
Zipes DP. Physicians Writing Fiction. Arrhythm Electrophysiol Rev. 2019 Jul;8(3):156-160. doi: 10.15420/aer.2019.8.3.ED1. PMID: 31463052; PMCID: PMC6702596.
Copy Download .nbib Format: NLM
Treatment outcome after radiochemotherapy in anal cancer patients staged with .

Clinical and translational radiation oncology

Braun LH, Reinert CP, Zips D, Nikolaou K, Pfannenberg C, Gani C.
PMID: 32642564
Clin Transl Radiat Oncol. 2020 Jun 18;24:83-87. doi: 10.1016/j.ctro.2020.06.008. eCollection 2020 Sep.

BACKGROUND: Anal cancer (AC) is a malignancy with increasing incidence and commonly treated with radiochemotherapy. Positron-emission tomography-computed tomography (PET/CT) has been shown to improve treatment outcome in various oncological diseases, however, for AC long-term outcome data is sparse. The...

Cite
Braun LH, Reinert CP, Zips D, et al. Treatment outcome after radiochemotherapy in anal cancer patients staged with . Clin Transl Radiat Oncol. 2020;24:83-87doi: 10.1016/j.ctro.2020.06.008.
Braun, L. H., Reinert, C. P., Zips, D., Nikolaou, K., Pfannenberg, C., & Gani, C. (2020). Treatment outcome after radiochemotherapy in anal cancer patients staged with . Clinical and translational radiation oncology, 2483-87. https://doi.org/10.1016/j.ctro.2020.06.008
Braun, L H, et al. "Treatment outcome after radiochemotherapy in anal cancer patients staged with ." Clinical and translational radiation oncology vol. 24 (2020): 83-87. doi: https://doi.org/10.1016/j.ctro.2020.06.008
Braun LH, Reinert CP, Zips D, Nikolaou K, Pfannenberg C, Gani C. Treatment outcome after radiochemotherapy in anal cancer patients staged with . Clin Transl Radiat Oncol. 2020 Jun 18;24:83-87. doi: 10.1016/j.ctro.2020.06.008. eCollection 2020 Sep. PMID: 32642564; PMCID: PMC7334798.
Copy Download .nbib Format: NLM
Integration of radiation oncology teaching in medical studies by German medical faculties due to the new licensing regulations : An overview and recommendations of the consortium academic radiation oncology of the German Society for Radiation Oncology (DEGRO).

Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al]

Dapper H, Belka C, Bock F, Budach V, Budach W, Christiansen H, Debus J, Distel L, Dunst J, Eckert F, Eich H, Eicheler W, Engenhart-Cabillic R, Fietkau R, Fleischmann DF, Frerker B, Giordano FA, Grosu AL, Herfarth K, Hildebrandt G, Kaul D, Kölbl O, Krause M, Krug D, Martin D, Matuschek C, Medenwald D, Nicolay NH, Niewald M, Oertel M, Petersen C, Pohl F, Raabe A, Rödel C, Rübe C, Schmalz C, Schmeel LC, Steinmann D, Stüben G, Thamm R, Vordermark D, Vorwerk H, Wiegel T, Zips D, Combs SE.
PMID: 34786605
Strahlenther Onkol. 2022 Jan;198(1):1-11. doi: 10.1007/s00066-021-01861-7. Epub 2021 Nov 16.

The new Medical Licensing Regulations 2025 (Ärztliche Approbationsordnung, ÄApprO) will soon be passed by the Federal Council (Bundesrat) and will be implemented step by step by the individual faculties in the coming months. The further development of medical studies...

Cite
Dapper H, Belka C, Bock F, et al. Integration of radiation oncology teaching in medical studies by German medical faculties due to the new licensing regulations : An overview and recommendations of the consortium academic radiation oncology of the German Society for Radiation Oncology (DEGRO). Strahlenther Onkol. 2021;198(1):1-11doi: 10.1007/s00066-021-01861-7.
Dapper, H., Belka, C., Bock, F., Budach, V., Budach, W., Christiansen, H., Debus, J., Distel, L., Dunst, J., Eckert, F., Eich, H., Eicheler, W., Engenhart-Cabillic, R., Fietkau, R., Fleischmann, D. F., Frerker, B., Giordano, F. A., Grosu, A. L., Herfarth, K., Hildebrandt, G., Kaul, D., Kölbl, O., Krause, M., Krug, D., Martin, D., Matuschek, C., Medenwald, D., Nicolay, N. H., Niewald, M., Oertel, M., Petersen, C., Pohl, F., Raabe, A., Rödel, C., Rübe, C., Schmalz, C., Schmeel, L. C., Steinmann, D., Stüben, G., Thamm, R., Vordermark, D., Vorwerk, H., Wiegel, T., Zips, D., & Combs, S. E. (2022). Integration of radiation oncology teaching in medical studies by German medical faculties due to the new licensing regulations : An overview and recommendations of the consortium academic radiation oncology of the German Society for Radiation Oncology (DEGRO). Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al], 198(1), 1-11. https://doi.org/10.1007/s00066-021-01861-7
Dapper, H, et al. "Integration of radiation oncology teaching in medical studies by German medical faculties due to the new licensing regulations : An overview and recommendations of the consortium academic radiation oncology of the German Society for Radiation Oncology (DEGRO)." Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al] vol. 198,1 (2022): 1-11. doi: https://doi.org/10.1007/s00066-021-01861-7
Dapper H, Belka C, Bock F, Budach V, Budach W, Christiansen H, Debus J, Distel L, Dunst J, Eckert F, Eich H, Eicheler W, Engenhart-Cabillic R, Fietkau R, Fleischmann DF, Frerker B, Giordano FA, Grosu AL, Herfarth K, Hildebrandt G, Kaul D, Kölbl O, Krause M, Krug D, Martin D, Matuschek C, Medenwald D, Nicolay NH, Niewald M, Oertel M, Petersen C, Pohl F, Raabe A, Rödel C, Rübe C, Schmalz C, Schmeel LC, Steinmann D, Stüben G, Thamm R, Vordermark D, Vorwerk H, Wiegel T, Zips D, Combs SE. Integration of radiation oncology teaching in medical studies by German medical faculties due to the new licensing regulations : An overview and recommendations of the consortium academic radiation oncology of the German Society for Radiation Oncology (DEGRO). Strahlenther Onkol. 2022 Jan;198(1):1-11. doi: 10.1007/s00066-021-01861-7. Epub 2021 Nov 16. PMID: 34786605; PMCID: PMC8594460.
Copy Download .nbib Format: NLM
Unpuzzling Friunavirus-Host Interactions One Piece at a Time: Phage Recognizes .

Antibiotics (Basel, Switzerland)

Domingues R, Barbosa A, Santos SB, Pires DP, Save J, Resch G, Azeredo J, Oliveira H.
PMID: 34827242
Antibiotics (Basel). 2021 Oct 26;10(11). doi: 10.3390/antibiotics10111304.

No abstract available.

Cite
Domingues R, Barbosa A, Santos SB, et al. Unpuzzling Friunavirus-Host Interactions One Piece at a Time: Phage Recognizes . Antibiotics (Basel). 2021;10(11)doi: 10.3390/antibiotics10111304.
Domingues, R., Barbosa, A., Santos, S. B., Pires, D. P., Save, J., Resch, G., Azeredo, J., & Oliveira, H. (2021). Unpuzzling Friunavirus-Host Interactions One Piece at a Time: Phage Recognizes . Antibiotics (Basel, Switzerland), 10(11), . https://doi.org/10.3390/antibiotics10111304
Domingues, Rita, et al. "Unpuzzling Friunavirus-Host Interactions One Piece at a Time: Phage Recognizes ." Antibiotics (Basel, Switzerland) vol. 10,11 (2021). doi: https://doi.org/10.3390/antibiotics10111304
Domingues R, Barbosa A, Santos SB, Pires DP, Save J, Resch G, Azeredo J, Oliveira H. Unpuzzling Friunavirus-Host Interactions One Piece at a Time: Phage Recognizes . Antibiotics (Basel). 2021 Oct 26;10(11). doi: 10.3390/antibiotics10111304. PMID: 34827242; PMCID: PMC8614642.
Copy Download .nbib Format: NLM
Repurposing Disulfiram for Targeting of Glioblastoma Stem Cells: An In Vitro Study.

Biomolecules

Zirjacks L, Stransky N, Klumpp L, Prause L, Eckert F, Zips D, Schleicher S, Handgretinger R, Huber SM, Ganser K.
PMID: 34827559
Biomolecules. 2021 Oct 21;11(11). doi: 10.3390/biom11111561.

Mesenchymal glioblastoma stem cells (GSCs), a subpopulation in glioblastoma that are responsible for therapy resistance and tumor spreading in the brain, reportedly upregulate aldehyde dehydrogenase isoform-1A3 (ALDH1A3) which can be inhibited by disulfiram (DSF), an FDA-approved drug formerly prescribed...

Cite
Zirjacks L, Stransky N, Klumpp L, et al. Repurposing Disulfiram for Targeting of Glioblastoma Stem Cells: An In Vitro Study. Biomolecules. 2021;11(11)doi: 10.3390/biom11111561.
Zirjacks, L., Stransky, N., Klumpp, L., Prause, L., Eckert, F., Zips, D., Schleicher, S., Handgretinger, R., Huber, S. M., & Ganser, K. (2021). Repurposing Disulfiram for Targeting of Glioblastoma Stem Cells: An In Vitro Study. Biomolecules, 11(11), . https://doi.org/10.3390/biom11111561
Zirjacks, Lisa, et al. "Repurposing Disulfiram for Targeting of Glioblastoma Stem Cells: An In Vitro Study." Biomolecules vol. 11,11 (2021). doi: https://doi.org/10.3390/biom11111561
Zirjacks L, Stransky N, Klumpp L, Prause L, Eckert F, Zips D, Schleicher S, Handgretinger R, Huber SM, Ganser K. Repurposing Disulfiram for Targeting of Glioblastoma Stem Cells: An In Vitro Study. Biomolecules. 2021 Oct 21;11(11). doi: 10.3390/biom11111561. PMID: 34827559; PMCID: PMC8615869.
Copy Download .nbib Format: NLM
Quantitative magnetic resonance imaging on hybrid magnetic resonance linear accelerators: Perspective on technical and clinical validation.

Physics and imaging in radiation oncology

Thorwarth D, Ege M, Nachbar M, Mönnich D, Gani C, Zips D, Boeke S.
PMID: 33458346
Phys Imaging Radiat Oncol. 2020 Oct 17;16:69-73. doi: 10.1016/j.phro.2020.09.007. eCollection 2020 Oct.

Many preclinical and clinical observations support that functional magnetic resonance imaging (MRI), such as diffusion weighted (DW) and dynamic contrast enhanced (DCE) MRI, might have a predictive value for radiotherapy. The aim of this review was to assess the...

Cite
Thorwarth D, Ege M, Nachbar M, et al. Quantitative magnetic resonance imaging on hybrid magnetic resonance linear accelerators: Perspective on technical and clinical validation. Phys Imaging Radiat Oncol. 2020;16:69-73doi: 10.1016/j.phro.2020.09.007.
Thorwarth, D., Ege, M., Nachbar, M., Mönnich, D., Gani, C., Zips, D., & Boeke, S. (2020). Quantitative magnetic resonance imaging on hybrid magnetic resonance linear accelerators: Perspective on technical and clinical validation. Physics and imaging in radiation oncology, 1669-73. https://doi.org/10.1016/j.phro.2020.09.007
Thorwarth, Daniela, et al. "Quantitative magnetic resonance imaging on hybrid magnetic resonance linear accelerators: Perspective on technical and clinical validation." Physics and imaging in radiation oncology vol. 16 (2020): 69-73. doi: https://doi.org/10.1016/j.phro.2020.09.007
Thorwarth D, Ege M, Nachbar M, Mönnich D, Gani C, Zips D, Boeke S. Quantitative magnetic resonance imaging on hybrid magnetic resonance linear accelerators: Perspective on technical and clinical validation. Phys Imaging Radiat Oncol. 2020 Oct 17;16:69-73. doi: 10.1016/j.phro.2020.09.007. eCollection 2020 Oct. PMID: 33458346; PMCID: PMC7807787.
Copy Download .nbib Format: NLM
Dynamics of HMBG1 (High Mobility Group Box 1) during radiochemotherapy correlate with outcome of HNSCC patients.

Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al]

Clasen K, Welz S, Faltin H, Zips D, Eckert F.
PMID: 34671818
Strahlenther Onkol. 2021 Oct 20; doi: 10.1007/s00066-021-01860-8. Epub 2021 Oct 20.

PURPOSE: High Mobility Group Box 1 (HMGB1) protein has been described as a consensus marker for immunogenic cell death (ICD) in cancer. To personalize treatments, there is a need for biomarkers to adapt dose prescription, concomitant chemotherapy, and follow-up...

Cite
Clasen K, Welz S, Faltin H, et al. Dynamics of HMBG1 (High Mobility Group Box 1) during radiochemotherapy correlate with outcome of HNSCC patients. Strahlenther Onkol. 2021;doi: 10.1007/s00066-021-01860-8.
Clasen, K., Welz, S., Faltin, H., Zips, D., & Eckert, F. (2021). Dynamics of HMBG1 (High Mobility Group Box 1) during radiochemotherapy correlate with outcome of HNSCC patients. Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al], . https://doi.org/10.1007/s00066-021-01860-8
Clasen, Kerstin, et al. "Dynamics of HMBG1 (High Mobility Group Box 1) during radiochemotherapy correlate with outcome of HNSCC patients." Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al] vol. (2021). doi: https://doi.org/10.1007/s00066-021-01860-8
Clasen K, Welz S, Faltin H, Zips D, Eckert F. Dynamics of HMBG1 (High Mobility Group Box 1) during radiochemotherapy correlate with outcome of HNSCC patients. Strahlenther Onkol. 2021 Oct 20; doi: 10.1007/s00066-021-01860-8. Epub 2021 Oct 20. PMID: 34671818.
Copy Download .nbib Format: NLM
Conversations With Legends in Cardiac Electrophysiology.

JACC. Clinical electrophysiology

Ajijola OA, Zipes D.
PMID: 32703580
JACC Clin Electrophysiol. 2020 Jul;6(7):905.e1-905.e3. doi: 10.1016/j.jacep.2020.06.003.

No abstract available.

Cite
Ajijola OA, Zipes D. Conversations With Legends in Cardiac Electrophysiology. JACC Clin Electrophysiol. 2020;6(7):905.e1-905.e3doi: 10.1016/j.jacep.2020.06.003.
Ajijola, O. A., & Zipes, D. (2020). Conversations With Legends in Cardiac Electrophysiology. JACC. Clinical electrophysiology, 6(7), 905.e1-905.e3. https://doi.org/10.1016/j.jacep.2020.06.003
Ajijola, Olujimi A, and Zipes, Douglas. "Conversations With Legends in Cardiac Electrophysiology." JACC. Clinical electrophysiology vol. 6,7 (2020): 905.e1-905.e3. doi: https://doi.org/10.1016/j.jacep.2020.06.003
Ajijola OA, Zipes D. Conversations With Legends in Cardiac Electrophysiology. JACC Clin Electrophysiol. 2020 Jul;6(7):905.e1-905.e3. doi: 10.1016/j.jacep.2020.06.003. PMID: 32703580.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 98 entries